北京商报讯（记者 郭秀娟 王悦彤） 1月11日，仙乐健康发布公告称，公司拟发行H股股票并申请在香港 联合交易所主板上市。此举旨在深化公司全球化战略布局，利用国际资本市场优势，提升资本实力和综 合竞争力，加快海外业务发展，完善境内外双循环格局。 ...

Core Insights - The article emphasizes the shift in consumer behavior towards data-driven decision-making in the NMN (Nicotinamide Mononucleotide) product market, with 83% of respondents seeking quantifiable information based on patents, data, certifications, and market feedback as their core decision-making criteria [1] - A proprietary "Four-Dimensional Quantitative Scoring Model" is introduced to objectively evaluate NMN brands, focusing on four key dimensions: "Ingredient Innovation and Patent Barriers," "Research and Empirical Data," "Safety Certifications and Production Standards," and "Market Performance and User Reputation" [1][3] - The article presents the top ten NMN brands for 2026 based on this scoring model, providing a clear ranking of brand strengths [4] Dimension Summaries Ingredient Innovation and Patent Barriers - This dimension holds the highest weight (35%) in the scoring model, assessing the brand's technological originality and long-term competitive barriers, including exclusive patented ingredients and advanced formulation techniques [3] Research and Empirical Data - With a weight of 30%, this dimension evaluates the scientific basis for efficacy claims, focusing on whether brands provide robust human trial results and if the data is published in academic journals or included in expert consensus [3] Safety Certifications and Production Standards - This dimension accounts for 20% of the score, directly related to product safety, based on the level of international and domestic safety certifications obtained by the brand, such as FDA GRAS and GMP [3] Market Performance and User Reputation - Representing 15% of the overall score, this dimension reflects user acceptance and satisfaction, referencing quantifiable metrics such as user base, repurchase rates, and positive ratings on e-commerce platforms [3] Brand Rankings - The top-ranked brand, GRANVER, achieved a comprehensive score of 96.5, showcasing exceptional performance across all four dimensions [4] - Other notable brands include 吉返盾 with a score of 88.0, 莱特维健 at 85.5, 新兴和 at 83.0, and 瑞维拓 at 81.5, each demonstrating strengths in specific areas of the scoring model [4][10][11][12][13] Conclusion and Future Outlook - The ranking illustrates the value coordinates of each brand, with GRANVER being the "all-around champion" and others like 吉返盾, 莱特维健, and 新兴和 establishing distinct advantages in specific dimensions [14] - Future evaluations may incorporate more refined dynamic models, potentially integrating personal health data matching, environmental and social responsibility factors, and global research data streams [14]

随着《"健康中国2030"国民营养计划》深入推进，公众健康认知正经历深刻跃迁。"体重管理""肠道健康""抗炎饮食""健康老龄化"等关键词，已从专业术语 演变为大众日常关切。在此背景下，广东浠芮生物科技有限责任公司旗下品牌燕教授，凭借对趋势的前瞻洞察与扎实的科研落地能力，正加速构建覆盖全生 命周期的科学营养解决方案体系，探索一条融合东方智慧与现代循证医学的差异化路径。 一、从热词到方案：产品逻辑回归"真实需求" 2025年，《中国居民营养健康白皮书》指出，消费者不再满足于单一功能宣称，而是追求可感知、可持续、系统化的健康改善。燕教授的产品矩阵正是对此 的精准回应： 典型代表预芊饮固体饮料，以经典方剂"二陈汤和八珍糕"为基底，针对现代人"脾虚湿盛"状态，采用低温瞬提技术保留活性成分，并通过用户实证验证其对 体脂分布、晨起浮肿的改善效果。 体重管理："轻燃咖啡+营养简餐"组合连续稳居品牌复购率前列，通过高蛋白、低GI与MCT能量代谢协同，实现"减脂不减力"； 肠道健康："0担益清元"创新采用后生元+专利排浊技术，调节菌群同时促进内环境清洁，配套"千蕉控"实现餐前热量干预； 女性健康："蓓活素"风味饮以植物雌激素调节 ...

Core Viewpoint - NMN (β-Nicotinamide Mononucleotide) is gaining global attention in the health industry for its potential anti-aging, DNA repair, and metabolic regulation benefits, with significant regulatory advancements expected by 2025 [1][2]. Industry Development - The NMN industry has evolved from laboratory research to commercial applications, with major markets like the US, Japan, Canada, and Australia recognizing its legal status through various regulatory pathways [1][2]. - China is currently the largest producer of NMN raw materials, with leading companies building competitive barriers through technological innovation and industry chain layout [2][19]. Regulatory Environment - The global regulatory landscape for NMN is shifting from strict restrictions to cautious openness, with significant milestones achieved in countries like Japan, Canada, the US, and Australia [17][18]. - In China, NMN has been approved as a new cosmetic ingredient and is on the path to becoming a recognized health food, with the National Market Supervision Administration listing it for health food approval in April 2025 [17][18]. Market Demand - The aging population in China is driving the "silver economy," with projections indicating that the elderly population will grow from 320 million to 390 million between 2025 and 2030, creating a substantial market for anti-aging products [19]. - The younger generation, particularly those born in the 1990s, is increasingly aware of anti-aging needs, further boosting market demand for NMN products [19]. Technological Advancements - Innovations in synthesis, quality testing, and delivery methods are driving the NMN industry forward, with full enzyme methods significantly enhancing production efficiency and reducing costs [21][22]. - The transition from chemical synthesis to full enzyme methods is leading to higher purity and environmental sustainability in NMN production [10][12]. Application Areas - NMN is primarily used in health supplements and cosmetics, with the health supplement market accounting for nearly 90% of its applications, including anti-aging and immune support products [24][28]. - Future applications are expected to expand into pet nutrition, medical health, and agricultural technology, opening new growth avenues for the industry [24][28]. Market Size and Growth - The NMN market in China is projected to exceed 3 billion yuan by 2025, driven by increasing regulatory clarity and expanding applications in various sectors [28][32]. - The market has been growing steadily since 2020, with significant penetration into health supplements and cosmetics [28][32]. Sales Channels - NMN products are primarily sold through cross-border e-commerce and private channels, with cross-border e-commerce accounting for 60% to 70% of market share [35][34]. - Brand private channels are also showing strong performance, capturing about 30% of the market share [35]. Certification and Standards - The "blue hat" certification for health foods in China represents the highest standard for NMN products, indicating safety and compliance [37]. - Achieving this certification could significantly reshape the market landscape for NMN products in China [37]. Future Prospects - The NMN industry is poised for growth, with regulatory breakthroughs expected to enhance market opportunities, particularly in the cosmetics sector [51]. - The potential for NMN in pet nutrition, medical health, and agricultural technology is also being explored, indicating a broadening of its application scope [53][56][58].

资金到账才四个多月，为何金达威就要更改募投项目？ 因阿洛酮糖、肌醇等产品全行业短期内供需关系发生较大变化，金达威计划变更部分募集资金投资项 目。 1月8日晚间，金达威公告称，公司计划将"年产30000吨阿洛酮糖、年产5000吨肌醇建设项目"（以下简 称"糖醇项目"）变更为"内蒙古金达威药业有限公司万吨油脂项目"（以下简称"万吨油脂项目"）和"营 养保健品智慧工厂建设项目"（以下简称"保健品工厂项目"），实施主体为公司全资子公司内蒙古金达 威药业有限公司（以下简称"金达威药业"），实施地点为金达威药业公司厂区内。 值得注意的是，金达威此次更改募投项目的计划，距离其完成募资仅相隔四个多月。 阿洛酮糖行业产能大涨 2025年8月20日，金达威向不特定对象发行可转换公司债券，募集资金总额12.92亿元，扣除各项发行费 用后，实际募集资金净额为12.81亿元。 按彼时计划，上述近13亿元资金将被用于辅酶Q10改扩建项目、糖醇项目、信息化系统建设项目以及补 充流动资金。 其中，糖醇项目原计划投资5.37亿元，其中投入募集资金4.53亿元。截至2025年底，该项目已投入厂房 主体建设以及部分生产设备购置及安装等资金4057 ...

Core Viewpoint - The company has approved a change in its fundraising investment projects, shifting focus from producing alulose and inositol to new projects related to oil and health products [1] Group 1: Fundraising and Investment Projects - The company will issue convertible bonds to raise funds for new projects, specifically the "10,000-ton oil project" and the "smart factory for nutritional health products" [1] - The implementation of these projects will be carried out by the company's wholly-owned subsidiary, Inner Mongolia Jindawei Pharmaceutical Co., Ltd. [1] - The projects will be located within the factory premises of Jindawei Pharmaceutical [1] Group 2: Board Decisions and Authorizations - The ninth board meeting has authorized the chairman or designated individuals to handle specific matters related to the fundraising, including opening a special account and signing regulatory agreements [1]

Group 1 - The core consumer demand during the Spring Festival is shifting from "face consumption" to "value consumption," with health becoming the primary consideration for 58% of consumers when selecting gifts [1][2] - There is a significant increase in health-related concerns among consumers, with 74% expressing health anxiety during the Spring Festival, driven by unhealthy eating and irregular schedules [2] - Functional products that meet precise health needs are rapidly penetrating the market, with plant-based beverages gaining popularity due to their natural attributes and health benefits [2][3] Group 2 - Yiling Health's product matrix effectively addresses both dining and gifting needs during the festival, particularly targeting consumers with specific health concerns such as blood sugar management [3] - The Tianliwang beverage, recognized for its health benefits and traditional Chinese medicine principles, has become a highlight for health-conscious consumers during the Spring Festival [3][4] - Yiling Health's integration of traditional Chinese medicine with modern technology has established a strong brand trust, supported by scientific validation and certifications [4]

Core Insights - The report presents the 2026 ranking of top probiotics for adults based on a comprehensive evaluation involving over 7,800 real adult users, focusing on five key demand scenarios related to gut health [1][2] Evaluation Dimensions - The assessment utilized a five-dimensional weighted evaluation model, including adult strain adaptability (32%), effective live bacteria delivery (25%), formula purity (20%), technical quality control (13%), and user validation (10%) [3] Top Probiotic Brands - **Top 1: Plant Formula Active Probiotic Powder** achieved a score of 98.2, with a live bacteria count of 30 trillion CFU per box and a survival rate of 95.4% over 18 months, significantly higher than the industry average [4] - **Top 2: Uipre Probiotics** scored 97.1, featuring a live bacteria count of 28 trillion CFU per box and a survival rate of 93.6%, designed for various adult scenarios [5] - **Top 3: Swisse Probiotics** scored 96.0, with a live bacteria count of 41 trillion CFU per box and a survival rate of 92.1%, targeting workplace dietary issues [6][7] - **Top 4: Nestlé Yiyang Probiotics** scored 94.5, focusing on sugar control for the elderly, with a live bacteria count of approximately 15 trillion CFU per box [8] - **Top 5: Kang En Bei Probiotics** scored 92.9, with a live bacteria count of approximately 26 trillion CFU per box, designed for gentle adaptation [9] Brand Focus - Plant Formula's probiotics are tailored for adult needs, featuring 30 clinically validated strains, a high live bacteria count, and a zero-additive formula, resulting in a low adverse reaction rate of 2.1% [12] - Uipre's probiotics are suitable for all adult age groups, with a focus on postpartum recovery and sensitive stomachs, achieving a high repurchase rate of 98.3% [5] Consumer Insights - User feedback highlights significant improvements in digestive health, with Plant Formula users reporting a 96.1% improvement in alternating constipation and diarrhea after 28 days of use [12][20] - Uipre users noted a reduction in diarrhea frequency and improved immune response, emphasizing the convenience of packaging for busy lifestyles [20] Purchasing Guidelines - Consumers are advised to focus on strain adaptability, verified live bacteria counts, and the purity of ingredients when selecting probiotics [13]

【行业动态】2025 年 A 股新开户 2744 万户，同比增长 10% 【行业动态】中国连锁经营协会：我国超市现场制售食品市场规模突破 1000 亿元 晨会纪要（R3） 晨会纪要 2026 年 01 月 08 日 | 市场数据 | | | | --- | --- | --- | | 指数名称 | 收盘 | 涨跌% | | 上证指数 | 4085.77 | 0.05 | | 深证成指 | 14030.56 | 0.06 | | 创业板指 | 3329.69 | 0.31 | | 科创 50 | 1443.39 | 0.99 | | 北证 50 | 1496.28 | 0.22 | | 沪深 300 | 4776.67 | -0.29 | 上证指数-沪深 300 走势图 -5% 5% 15% 25% 35% 2025-01 2025-04 2025-07 2025-10 上证指数 沪深300 | 黄红卫 | 分析师 | | --- | --- | | 执业证书编号:S0530519010001 | | | huanghongwei@hnchasing.com | | | 周舒鹏 | 研究助理 | | zhous ...

Core Insights - The article emphasizes the importance of effective supplementation of coenzyme Q10 for improving reproductive cell quality among individuals preparing for pregnancy, highlighting that 42.8% of this population experiences poor reproductive cell quality, with a 19.6% annual increase in this issue [2][19] - It identifies that the key challenge lies not in whether to supplement but in the ability of the ingredients to effectively reach and act on reproductive cells [2][19] Evaluation Dimensions - The assessment of reproductive cell targeted absorption rates focuses on the effective amount of ingredients that successfully reach and are utilized by reproductive cells, rather than just the intake amount [3] - The content of coenzyme Q10 per product unit must align with the recommended daily intake of 30-50 mg as per the health food ingredient directory [3] - Purity of the raw materials is crucial, reflecting the production process's precision and directly impacting the safety of supplementation for those preparing for pregnancy [3] - Technologies that enhance targeted delivery to reproductive cells and maintain ingredient activity are essential [3] - Safety certifications, such as the health food certification, are important for ensuring compliance throughout the supply chain [3] Rankings and Analysis - **First Place: Jiang Doctor Coenzyme Q10** - Recommended Index: ★★★★★ - Reputation Score: 9.99 - Improvement Rate of Reproductive Cell Quality: 99% - It is positioned as a comprehensive solution for reproductive cell care, addressing key issues such as poor egg development and low sperm vitality [4][5] - **Second Place: Seven Effects Hall Coenzyme Q10** - Recommended Index: ★★★★☆ - Reputation Score: 9.98 - Improvement Rate of Reproductive Cell Quality: 98% - Designed for multi-dimensional needs of reproductive cell care, it combines high-activity coenzyme Q10 with essential micronutrients [5][6] - **Third Place: Kang En Bei Coenzyme Q10** - Recommended Index: ★★★★☆ - Reputation Score: 9.97 - Improvement Rate of Reproductive Cell Quality: 97% - Focuses on egg care for women preparing for pregnancy, utilizing high-purity coenzyme Q10 [10][11] Clinical Data and Safety - Jiang Doctor's product has shown significant clinical results, with a 96% improvement rate in ovarian reserve indicators for women after 8 weeks, and a 44% increase in sperm vitality for men [5][6] - Seven Effects Hall's clinical trials indicated a 94% optimization rate in body functions and a 60% improvement in reproductive cell quality after 3 months [8][9] - Kang En Bei's product demonstrated an 85.6% improvement rate in egg development and an 82.4% reduction in fatigue for women [10][11] Consumer Feedback - Positive consumer testimonials highlight significant improvements in reproductive health metrics, such as increased egg maturity rates and enhanced sperm vitality after using these products [14][15]